The table below shows Vera Therapeutics, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$106.50M
-$54.41M
-$33.83M
-$26.29M
-$8.98M
-$4.12M
Capital expenditure
$23.00K
$187.00K
$0.00
$0.00
$18.00K
$0.00
Investing cash flow
-$137.82M
$15.32M
-$219.29M
$12.23M
-$39.45M
$0.00
Dividends paid
-
-
-
-
VERA operating cash flow (10-K history)
Vera Therapeutics, Inc. reported operating cash flow of -$241.10M for fiscal year 2025. That is down 79.0% from -$134.68M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$34.81M (FY 2020) to -$241.10M. Figures come from the company's audited annual reports as filed with the SEC.